squamous cell carcinoma of rectum
squamous cell carcinoma of rectum
Explore linked clinical trials. Standard reference: MONDO:00185152 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer | Blood-Borne Infections, Digestive System Diseases, Digestive System Neoplasms, Genital Diseases, HIV infectious disease, Infections, Neoplasms by Site, RNA Virus Infections, Urogenital Diseases, anal margin squamous cell carcinoma, anal squamous cell carcinoma, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, immune system disorder, inborn error of immunity, infectious disease, intestinal disorder, lentivirus infection, neoplasm, rectal disorder, rectal neoplasm, sexually transmitted disease, squamous cell carcinoma of rectum, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-10-05 | NCT04929028 | |
| Radical Concurrent Chemoradiotherapy With DDP/5-FU and PD-1 Antibody for Non-metastatic Rectal Squamous Cell Carcinoma | squamous cell carcinoma of rectum | Recruiting | Phase 2 | 2026-07-01 | NCT06364384 |